Impact of renin-angiotensin system inhibitors on clinical outcomes and ventricular remodelling after transcatheter aortic valve implantation: rationale and design of the RASTAVI randomised multicentre study.
Ignacio J Amat-SantosPablo CataláFelipe Diez Del HoyoJose A Fernandez-DiazJuan H Alonso-BrialesMaría Del TrigoAnder RegueiroPablo Juan-SalvadoresVicenç SerraEnrique Gutierrez-IbanesAntonio J Muñoz-GarcíaLuis Nombela-FrancoManel SabateVictor A Jimenez-DiazBruno García Del BlancoJavier LópezLuis H Varela-FalcónTeresa SevillaRoman ArnoldAna RevillaJ Alberto San RomanPublished in: BMJ open (2018)
NCT03201185.
Keyphrases
- transcatheter aortic valve implantation
- aortic valve replacement
- clinical trial
- aortic valve
- aortic stenosis
- open label
- left ventricular
- double blind
- heart failure
- study protocol
- placebo controlled
- catheter ablation
- transcatheter aortic valve replacement
- ejection fraction
- atrial fibrillation
- coronary artery disease